| |
 |
Pfizer Inc. Patents |
|
Assignee: Pfizer Inc.
Address: New York, NY
No. of patents: 3349
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| RE39558 |
5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating |
April 10, 2007 |
| Compounds of this formula ##STR00001## are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease. |
| RE39419 |
Estrogen agonist/antagonist metabolites |
December 5, 2006 |
| This invention relates to compounds that are mammalian metabolites of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahyd- ro-naphthalene-2-ol. The compounds of the invention can be used as standards for analytical assays or as intermediates for the further chemi |
| RE39149 |
Method of administering azithromycin |
June 27, 2006 |
| An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages c |
| RE38524 |
Dipeptide derivatives as growth hormone secretagogues |
June 1, 2004 |
| This invention is directed to compounds of the formula ##STR1##and the pharmaceutically-acceptable salts thereof, where the substituents are as defined in the Specification, which are growth hormone secretogogues and which increase the level of endogenous growth hormone. The compound |
| RE35865 |
Preparation of glutaric acid derivatives |
July 28, 1998 |
| The Invention provides a process for preparing a compound of the formula: ##STR1## or a base salt thereof, wherein R.sup.2 is hydrogen or C.sub.1 -C.sub.6 alkyl optionally substituted by up to 3 substituents each independently selected from the group consisting of C.sub.1 -C.sub.6 al |
| RE29669 |
Production of 4-hydroxy-1,2-benzothiazine-3-carboxamides |
June 13, 1978 |
| A process for the synthesis of N-aryl-3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides by treatment of N-aryl-N'-alkyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides, useful intermediates for said process, with an alkali or alkaline earth metal hydrid |
| RE29668 |
Glycineamides |
June 13, 1978 |
| A process for the synthesis of N-aryl-3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides by treatment of N-aryl-N'-alkyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides, useful intermediates for said process, with an alkali or alkaline earth metal hydrid |
| D499023 |
Liquid measuring vessel |
November 30, 2004 |
|
| D450153 |
Applicator |
November 6, 2001 |
|
| D444056 |
Blister package dispenser |
June 26, 2001 |
|
| D440871 |
Blister package |
April 24, 2001 |
|
| D437407 |
Pharmaceutical tablet |
February 6, 2001 |
|
| D434136 |
Pharmaceutical tablet |
November 21, 2000 |
|
| D434135 |
Pharmaceutical tablet |
November 21, 2000 |
|
| D433750 |
Pharmaceutical tablet |
November 14, 2000 |
|
| D433501 |
Pharmaceutical tablet |
November 7, 2000 |
|
| D433500 |
Pharmaceutical tablet |
November 7, 2000 |
|
| D433499 |
Pharmaceutical tablet |
November 7, 2000 |
|
| D433122 |
Pharmaceutical tablet |
October 31, 2000 |
|
| D433121 |
Pharmaceutical tablet |
October 31, 2000 |
|
| D432714 |
Applicator |
October 24, 2000 |
|
| D432641 |
Pharmaceutical tablet |
October 24, 2000 |
|
| D431093 |
Applicator |
September 19, 2000 |
|
| D430703 |
Applicator |
September 5, 2000 |
|
| D415272 |
Pharmaceutical tablet |
October 12, 1999 |
|
| D414552 |
Pharmaceutical tablet |
September 28, 1999 |
|
| D414551 |
Pharmaceutical tablet |
September 28, 1999 |
|
| D414259 |
Pharmaceutical tablet |
September 21, 1999 |
|
| D413973 |
Pharmaceutical tablet |
September 14, 1999 |
|
| D413972 |
Pharmaceutical tablet |
September 14, 1999 |
|
| D410842 |
Bottle protecting container |
June 8, 1999 |
|
| D400434 |
Combined liquid measuring vessel and bottle |
November 3, 1998 |
|
| D392562 |
Blister pack |
March 24, 1998 |
|
| D363430 |
Container having a curved back panel |
October 24, 1995 |
|
| D353225 |
Nit comb |
December 6, 1994 |
|
| D336540 |
Nit comb |
June 15, 1993 |
|
| D311867 |
Cosmetic and perfume bottle |
November 6, 1990 |
|
| D308428 |
Cosmetic case |
June 5, 1990 |
|
| D286137 |
Combined pill dispenser and cover |
October 14, 1986 |
|
| D273704 |
Orthopedic surgery brush |
May 1, 1984 |
|
| D263172 |
Pharmaceutical tablet |
February 23, 1982 |
|
| D251823 |
Folding garden tool |
May 15, 1979 |
|
| D245316 |
Liquid dispenser |
August 9, 1977 |
|
| 7417140 |
7.alpha.-Hydroxyacetyl and 7.alpha.-Hydroperoxyacetyl-substituted steroid compounds |
August 26, 2008 |
| The present invention involves intermediates, including a 7.alpha.-substituted steroid (II), ##STR00001## and processes which are used to prepare eplerenone, a useful pharmaceutical agent. |
| 7417041 |
Imidazopyrimidines as transforming growth factor (TGF) inhibitors |
August 26, 2008 |
| Novel fused heteroaromatic compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth fa |
| 7414127 |
7 .alpha.-Enedione-substituted steroid compounds |
August 19, 2008 |
| The present invention involves intermediates, including a 7.alpha.-substituted steroid (II), ##STR00001## and processes which are used to prepare eplerenone, a useful pharmaceutical agent. |
| 7414071 |
Methods of treatment with selective EP4 receptor agonists |
August 19, 2008 |
| The present invention provides a method of treating hypertension, liver failure, loss of patency of ductus arteriosus, glaucoma or ocular hypertension in a patient, comprising administering to the patient a therapeutically effective amount of a selective EP.sub.4 receptor agonist of |
| 7411062 |
7.alpha.-biscarbonyl-substituted steroid compounds |
August 12, 2008 |
| The present invention involves intermediates, including a 7.alpha.-substituted steroid (II), ##STR00001## and processes which are used to prepare eplerenone, a useful pharmaceutical agent. |
| 7411057 |
Nucleic acids encoding human monoclonal antibodies to CTLA-4 |
August 12, 2008 |
| In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucelotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly conti |
| 7408068 |
Compounds for the treatment of neurodegenerative disorders |
August 5, 2008 |
| The present invention relates to compounds of the Formula ##STR00001## wherein R.sup.3, R.sup.5, R.sup.7, U, X, Y and Z are as defined. Compounds of the Formula I have activity inhibiting production of A.beta.-peptide. This invention also relates to pharmaceutical compositions and me |
|
|
|
